Anna-Shari Melin

• Crown Bioscience in its acquisition of the IndivuServ business unit of Indivumed GmbH.
• Advising RTI Surgical Inc. in its contemplated acquisition of a provider of spinal implant solutions that serve to address the unmet clinical needs of spine surgeons and their patients.
• Advising client on contemplated acquisition of leading specialty generics company.
• Advising a premier designer, developer, and manufacturer of medical devices focused on preventing infections and supporting patients and caregivers across the acute care markets on its asset purchase of a medical restraints manufacturer active on the EU and in particular the German market.
• Advising a U.S.-based multinational medical devices and healthcare company under EU and German law with respect to various aspects of their business, including the disposal of medical devices under relevant electronic waste and infectious disease laws; pricing and advertising strategies prior to obtaining CE marking; and licensing requirements applicable to a broker company manufacturing pet food from medicinal product scraps.
• Counselling one of the largest Japanese pharmaceutical companies under EU and German law relevant to early access programs, including on agreements with German university hospitals covering the provision of a monoclonal antibody in the context of an individual treatment attempt.
• Advising a Germany-based multinational company in the context of an FCPA/anti-corruption risk assessment of operations in various EU countries.
• Advising an EU multinational food-products corporation on EU and German law relevant to the labelling, manufacture and reimbursement of infant formula and follow-on products.
• Advising a U.S.-based international biopharmaceutical company under German law on pre-licensing activities relating to its pipeline product.
• Counselling a global alternative asset manager on in its due diligence process while acquiring a company focused on medicines for the central nervous system.
• Advising a multinational medical device company under German law with respect to a wide variety of aspects of their business, including on transparency requirements; cost coverage tools intended to be used in advertising; ownership rights of implantable devices; the preparation of educational grant agreements; and technician presence in an operating theater.

Anna-Shari is involved in the firm’s Emerging Enterprises Pro Bono Program, which provides free legal support to eligible small- and medium-sized for-profit enterprises and market-focused non-governmental organizations and non-profits that have a clear social impact in developing countries across Africa, Asia, Central and South America, and the Caribbean.

• Munich Bar Association (Rechtsanwaltskammer München).